MIJ821 (onfasprodil) in healthy volunteers: First‐in‐human, randomized, placebo‐controlled study (single ascending dose and repeated intravenous dose)

This single‐center study administered MIJ821 (onfasprodil) as an intravenous infusion to healthy volunteers and included two parts: a single ascending dose study (Part 1) and a repeated intravenous dose study (Part 2). Primary objective was to evaluate the safety and tolerability of single ascending...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez‐Mancilla, Baltazar, Levy, Jeffrey A., Ganesan, Subramanian, Faller, Thomas, Issachar, Gil, Peremen, Ziv, Laufer, Offir, Shani‐Hershkovich, Revital, Biliouris, Kostas, Walker, Ela, Healy, Mark P., Sverdlov, Oleksandr, Desai, Sachin, Ghaemi, S. Nassir, Cha, Jang‐Ho, Shanker, Y. Gopi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651655/
https://www.ncbi.nlm.nih.gov/pubmed/37817426
http://dx.doi.org/10.1111/cts.13623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651655/
https://www.ncbi.nlm.nih.gov/pubmed/37817426
http://dx.doi.org/10.1111/cts.13623

Ejemplares similares